Minimally Invasive Molecular Approaches for the Diagnosis of Barrett's Esophagus and Esophageal Adenocarcinoma
for
Barrett Esophagus, Esophageal Adenocarcinoma
Location: Eau Claire WI, Rochester MN, Austin MN
Sponsor: Mayo Clinic
Sex: All
Age: 18 - 70+
Code: NCT03961945
Recruiting
Study of TDXd, Chemotherapy, Pembrolizumab, and Trastuzumab in First-Line Metastatic HER2-Positive Gastric or Gastroesophageal Junction Cancer
for
Gastric Cancer, Gastroesophageal Junction Cancer
Location: Boston MA, The Bronx NY, New York NY, Hershey PA,
Sponsor: Daiichi Sankyo
Sex: All
Age: 18+
Code: NCT06731478
Phase3, Recruiting
A Phase 1 Study of the Safety and Tolerability of CTX-10726
for
Gastroesophageal Cancer (GC), Hepatocellular Carcinoma (HCC),
Location: Lake Success NY, Pittsburgh PA, Greenville SC,
Sponsor: Compass Therapeutics
Sex: All
Age: 18+
Code: NCT07419841
Phase1, Recruiting
A Study to Investigate Safety of AZD6750 in Adult Participants With Select Advanced or Metastatic Solid Tumors
for
Melanoma, Non-small Cell Lung Cancer,
Location: Fairfax VA, Pittsburgh PA, Grand Rapids MI, St Louis MO,
Sponsor: AstraZeneca
Sex: All
Age: 18+
Code: NCT07115043
Phase1, Phase2, Recruiting
Testing the Combination of the Anticancer Drugs Trastuzumab Deruxtecan (DS-8201a) and Azenosertib (ZN-c3) in Patients With Stomach or Other Solid Tumors
for
Clinical Stage III Gastric Cancer AJCC v8,
Location: Houston TX
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT06364410
Phase1, Recruiting
Interested in new esophageal cancer trials?
Get alerts for new trials in your area by subscribing now
Givastomig Combined With Nivolumab and Chemotherapy in Adults With CLDN18.2 Positive Metastatic Gastric Cancer (GIVA-2)
Sponsor: Weill Medical College of Cornell University
Sex: All
Age: 18+
Code: NCT06340711
Phase2, Recruiting
Spevatamig (PT886) as Monotherapy or in Combination With Chemo and/or ICI, for the Treatment of Patients With Advanced Gastric, Gastroesophageal Junction, Pancreatic Ductal or Biliary Tract Carcinomas (the TWINPEAK Study)
for
Gastric or Gastroesophageal Junction Adenocarcinoma,
Location: Fairfax VA, Durham NC, Pittsburgh PA, Louisville KY,
Sponsor: Phanes Therapeutics
Sex: All
Age: 18+
Code: NCT05482893
Phase1, Phase2, Recruiting
Assessment of a Minimally Invasive Collection Device for Molecular Analysis of Esophageal Samples
for
Barrett Esophagus, Barretts Esophagus With Dysplasia,
Location: Jacksonville FL, Rochester MN, Scottsdale AZ
Sponsor: Mayo Clinic
Sex: All
Age: 18 - 70+
Code: NCT06071845
Recruiting
Preoperative Hypofractionated Radiotherapy With FOLFOX for Esophageal or Gastroesophageal Junction Adenocarcinoma
for
Clinical Stage I Esophageal Adenocarcinoma AJCC v8,
Location: Rochester MN
Sponsor: Mayo Clinic
Sex: All
Age: 18+
Code: NCT06078709
Phase2, Recruiting
A Study of TRK-950 When Used in Combination With Ramucirumab and Paclitaxel in Patients With Gastric Cancer
for
Gastric Adenocarcinoma, Gastric Cancer,
Location: Plano TX, Dallas TX, Grapevine TX, Arlington TX,
Sponsor: Toray Industries, Inc
Sex: All
Age: 18+
Code: NCT06038578
Phase2, Recruiting
A Phase 1/1b Study of IAM1363 in HER2 Cancers
for
HER2 Mutation-Related Tumors, HER2, HER2-positive Breast Cancer,
Location: Boston MA, Lebanon NH, New York NY, New Brunswick NJ,
Sponsor: Iambic Therapeutics, Inc
Sex: All
Age: 18+
Code: NCT06253871
Phase1, Recruiting
A Study of Sigvotatug Vedotin in Advanced Solid Tumors
for
Carcinoma, Non-Small Cell Lung,
Location: Boston MA, Newton MA, Shirley NY, Riverhead NY,
Sponsor: Seagen, a wholly owned subsidiary of Pfizer
Sex: All
Age: 18+
Code: NCT04389632
Phase1, Recruiting
Advanced Endo-therapeutic Procedure : Registry-based Observational Study
for
Zenker Diverticulum, Polyp of Colon, Colo-rectal Cancer
Trans-Pacific Multicenter Collaborative Study of Minimally Invasive Proximal Versus Total Gastrectomy for Proximal Gastric and Gastroesophageal Junction Cancers
for
Gastrostomy, Gastric, GastroEsophageal Cancer
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center
Sex: All
Age: 18+
Code: NCT05205343
Recruiting
Virtual Reality for GI Cancer Pain to Improve Patient Reported Outcomes
for
Cancer Pain, Visceral Pain, Gastrointestinal Neoplasms,
Location: Los Angeles CA
Sponsor: Cedars-Sinai Medical Center
Sex: All
Age: 18 - 70+
Code: NCT04907643
Recruiting
A Phase â…¢ Clinical Study of HLX22 in Combination With Trastuzumab and Chemotherapy for the Treatment of Gastroesophageal Junction and Gastric Cancer